Induced oral mucositis in Wistar rats treated with different drugs: Preventive potential in cytokine production
Open Access
- 1 June 2021
- journal article
- research article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 14 (6) , 1-10
Abstract
The aim of the present study was to investigate the preventive potential of pentoxifylline, atorvastatin and trans-caryophyllene in oral mucositis through histopathological analysis of wounds in the oral mucosa of Wistar rats treated with 5-FU, and to evaluate the immunomodulatory effect of these drugs on serum nitrite production, in situ IFN-gamma, TNF-alpha and TGF-beta, and TNF-alpha in tissues. A total of 32 male Wistar rats with an average age of 9 weeks and an average body weight of 250 g were divided into four treatment groups: Saline, trans-caryophyllene, pentoxifylline and atorvastatin. Oral mucositis was then induced. On days 3 and 4, the mucosa of the mouth of eight pre-treated animals in each group was bilaterally scarified twice with the tip of a sterile needle, with an anesthetic solution. Mucosal samples from animals treated with trans-caryophyllene preserved a thin epithelial lining associated with focal perivascular inflammatory infiltrates. Pentoxifylline-treated animals exhibited total epithelial loss in oral wounds with severe inflammatory infiltrates and mild re-epithelialization associated with mild and diffuse inflammatory infiltrates. Samples from atorvastatin-treated animals exhibited no epithelial dissolution, with preserved thin lining and mild diffuse inflammatory infiltrates. The analysis of TNF-alpha expression revealed improved results in trans-caryophyllene animals. The analysis of TGF-beta expression revealed positive mononuclear cells. Preventive treatment with atorvastatin was demonstrated to modulate the serum expression levels of TNF-alpha during all stages of the experiment. Treatment with trans-caryophyllene modulated serum IFN-gamma levels negatively, whereas treatment with atorvastatin and trans-caryophyllene maintained lower levels of IFN-gamma compared with the control group.Keywords
This publication has 42 references indexed in Scilit:
- Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patientsSupportive Care in Cancer, 2012
- Chemistry and Biological Activities of Terpenoids from Copaiba (Copaifera spp.) OleoresinsMolecules, 2012
- Management of Oral Mucositis in Patients Who Have CancerDental Clinics of North America, 2008
- A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2Molecular Cancer Therapeutics, 2007
- AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDSAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- PaliferminDrugs, 2005
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- Prototype Foamy Virus Envelope Glycoprotein Leader Peptide Processing Is Mediated by a Furin-Like Cellular Protease, but Cleavage Is Not Essential for Viral InfectivityJournal of Virology, 2004
- Investigation on the wound healing activity of oleo‐resin from Copaifera langsdorffi in ratsPhytotherapy Research, 2002
- PentoxifyllineDrugs, 1987